首页> Epigenomics> Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.

Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tao,He

第一单位： Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing 100853, China.;Department of Pathology, The Affiliated Hospital of Logistics University of Chinese People's Armed Police Force, Tianjin 300162, China.

作者： Tao,He ^[1] ; Meiying,Zhang ^[2] ; Ruipan,Zheng ^[2] ; Shufang,Zheng ^[3] ; Enqiang,Linghu ^[4] ; James G,Herman ^[5] ; Mingzhou,Guo ^[4]

作者单位： Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing 100853, China.;Department of Pathology, The Affiliated Hospital of Logistics University of Chinese People's Armed Police Force, Tianjin 300162, China. ^[1] Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing 100853, China.;Medical College, NanKai University, Tianjin 300071, China. ^[2] Department of Pathology, The Affiliated Hospital of Logistics University of Chinese People's Armed Police Force, Tianjin 300162, China. ^[3] Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing 100853, China. ^[4] Medical College, NanKai University, Tianjin 300071, China. ^[5]

关键词 DNA damage repair SLFN11 cisplatin colorectal cancer epigenetics methylation